Article Versions Notes

Saito S, Yoshino H, Yokoyama S, Tominaga M, Li G, Arima J, Kawahara I, Fukuda I, Mitsuke A, Sakaguchi T, et al. Targeting Heat Shock Transcription Factor 4 Enhances the Efficacy of Cabozantinib and Immune Checkpoint Inhibitors in Renal Cell Carcinoma. International Journal of Molecular Sciences. 2025; 26(4):1776. https://doi.org/10.3390/ijms26041776

Saito, Saeki, Hirofumi Yoshino, Seiya Yokoyama, Mitsuhiko Tominaga, Gang Li, Junya Arima, Ichiro Kawahara, Ikumi Fukuda, Akihiko Mitsuke, Takashi Sakaguchi, and et al. 2025. "Targeting Heat Shock Transcription Factor 4 Enhances the Efficacy of Cabozantinib and Immune Checkpoint Inhibitors in Renal Cell Carcinoma" International Journal of Molecular Sciences 26, no. 4: 1776. https://doi.org/10.3390/ijms26041776

Saito, S., Yoshino, H., Yokoyama, S., Tominaga, M., Li, G., Arima, J., Kawahara, I., Fukuda, I., Mitsuke, A., Sakaguchi, T., Inoguchi, S., Matsushita, R., Yamada, Y., Tatarano, S., Tanimoto, A., & Enokida, H. (2025). Targeting Heat Shock Transcription Factor 4 Enhances the Efficacy of Cabozantinib and Immune Checkpoint Inhibitors in Renal Cell Carcinoma. International Journal of Molecular Sciences, 26(4), 1776. https://doi.org/10.3390/ijms26041776